“jeremy-levin” Archives

in
Entry Author Date Location
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
ICER, CRISPR, Biotech Activism & More: The X of the Year Finalists 08/15/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Don’t Be Boston 2.0, And Photos From “Bringing Back the Expats” 06/27/18 New York
Win Free Tickets to New York Biotech: Bringing Back the Expats! 05/31/18 National
Check Out the Agenda for New York Biotech: Bringing Back the Expats 05/23/18 National
Super Saver Rate Ending—NY Biotech: Bringing Back the Expats on 6/21 04/11/18 National
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA 09/07/17 National
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers 08/24/17 Boston
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
ZappRx Gets $25M to Push E-Prescription Tools for Specialty Meds 04/20/17 Boston
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
On Tap For “What’s Hot” on May 11: Opioid Crisis, Immigration & More 04/13/17 Boston
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Creating Bio “Gestalt” And Photos From New York Life Sciences 2021 12/19/16 New York
Hurry and Save 20 Percent on NY Life Sciences 2021 12/08/16 New York
At NY Life Sci 2021, Yancopoulos, Dunn & More to Ponder NYC’s Bio Future 10/19/16 New York
Defying Patient Pressure, Anthem Says No to Sarepta’s Duchenne Drug 10/07/16 Boston
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer 08/31/15 New York
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Levin Steps in as Ovid CEO, Confirms Plan to Target Rare Neuro Diseases 04/16/15 New York
Page 1 of 2 next page »